Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis center

BACKGROUND: Severe familial hypercholesterolemia (FH) individuals, refractory to conventional lipid-lowering medications are at exceptionally high risk of cardiovascular events. The established therapeutic option of last choice is lipoprotein apheresis (LA). Herein, it was sought to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mickiewicz, Agnieszka, Borowiec-Wolna, Justyna, Bachorski, Witold, Gilis-Malinowska, Natasza, Gałąska, Rafał, Raczak, Grzegorz, Chmara, Magdalena, Wasąg, Bartosz, Jaguszewski, Miłosz J., Fijałkowski, Marcin, Gruchała, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2020
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083034/
https://www.ncbi.nlm.nih.gov/pubmed/30234904
http://dx.doi.org/10.5603/CJ.a2018.0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083034/
https://www.ncbi.nlm.nih.gov/pubmed/30234904
http://dx.doi.org/10.5603/CJ.a2018.0100

Ejemplares similares